Dr. Timothy L. Cannon
Claim this profileInova Schar Cancer Institute
Area of expertise
Cancer
Timothy L. Cannon has run 6 trials for Cancer. Some of their research focus areas include:
Solid Tumors
Timothy L. Cannon has run 5 trials for Solid Tumors. Some of their research focus areas include:
Affiliated Hospitals
Inova Schar Cancer Institute
Inova Fairfax Hospital
Clinical Trials Timothy L. Cannon is currently running
Targeted Therapy
for Advanced Stage Cancer
The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*
Recruiting
1 award
Phase 2
9 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about Timothy L. Cannon
Clinical Trial Related
4 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Timothy L. Cannon has experience with
- Palbociclib
- Binimetinib
- Ipatasertib
- Larotrectinib
- Afatinib
- Olaparib
Breakdown of trials Timothy L. Cannon has run
Cancer
Solid Tumors
Colorectal Cancer
Ovarian Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Timothy L. Cannon specialize in?
Timothy L. Cannon focuses on Cancer and Solid Tumors. In particular, much of their work with Cancer has involved KRAS positive patients, or patients who are BRAF positive.
Is Timothy L. Cannon currently recruiting for clinical trials?
Yes, Timothy L. Cannon is currently recruiting for 3 clinical trials in Fairfax Virginia. If you're interested in participating, you should apply.
Are there any treatments that Timothy L. Cannon has studied deeply?
Yes, Timothy L. Cannon has studied treatments such as Palbociclib, Binimetinib, Ipatasertib.
What is the best way to schedule an appointment with Timothy L. Cannon?
Apply for one of the trials that Timothy L. Cannon is conducting.
What is the office address of Timothy L. Cannon?
The office of Timothy L. Cannon is located at: Inova Schar Cancer Institute, Fairfax, Virginia 22042 United States. This is the address for their practice at the Inova Schar Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.